Le Lézard
Classified in: Health
Subject: CPG

CareRx Corporation Welcomes Ontario Government's Pause of Planned Fee Changes


TORONTO, April 1, 2024 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, welcomes the decision by the Ontario Government to pause the previously scheduled changes to long-term care pharmacy funding that were scheduled to go into effect on April 1, 2024.

Under certain amendments to the Ontario Drug Benefit Act that came into effect on January 1, 2020, the reimbursement model for long-term care pharmacies in Ontario was changed from a fee-for-service model to a fee-per-bed capitation model under which pharmacies receive a fixed professional fee for all pharmacy services provided to residents in long-term care homes. The fee for 2024, which is currently prescribed at $1,500 per bed serviced, was scheduled to decline to $1,400 per bed serviced on April 1, 2024.

"Pharmacy service providers like CareRx are highly integrated in long-term care homes and collaborate with physicians and nurses to help improve medication and labour management," said Puneet Khanna, President and Chief Executive Officer of CareRx. "This pause in the fee reduction will ensure that long-term care pharmacies can continue to deliver the same exceptional partnership and essential service offering to long-term care homes and help alleviate the many burdens home staff are facing. We want to thank Minister Jones, Minister Cho, their respective staff and the Ontario Government for recognizing the value of long-term care pharmacy service providers. We look forward to continuing to work collaboratively with the Ontario Government to help demonstrate how long-term care pharmacies can continue to be partners in helping achieve the goal of ensuring four hours of direct resident care per day."

About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve approximately 91,000 residents in over 1,500 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.

SOURCE CareRX Corporation


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: